Millennium Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
Millennium Management's COGT Position: Q3 2026 in Review
Millennium Management reduced its Cogent Biosciences (COGT) stake by 64% in Q3 2026, selling an estimated $21.5M and leaving 324,672 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2256.
Millennium Management first reported a position in COGT in Q1 2018 and has held it in 29 quarters since. The position peaked at $45.9M in Q1 2026. 316 funds tracked by Wall St. Rank hold COGT as of Q3 2026.
- Millennium Management held 324,672 shares of Cogent Biosciences worth $10.4M as of Q3 2026.
- Millennium Management sold 583,040 Cogent Biosciences shares in Q3 2026, an estimated $21.5M.
- Cogent Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #2256 holding.
- Millennium Management first reported a position in Cogent Biosciences in Q1 2018 and has held it in 29 quarters since.
- Millennium Management's Cogent Biosciences position peaked at $45.9M in Q1 2026.
- 316 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.